How clinical biobanks can support precision medicine: from standardized preprocessing to treatment guidance

被引:0
|
作者
Fluegge, Friedemann [1 ]
Figge, Lena [1 ]
Duhm-Harbeck, Petra [2 ]
Kammler, Rosita [3 ,4 ,5 ]
Habermann, Jens K. [1 ,5 ,6 ,7 ]
机构
[1] Univ Lubeck, Interdisciplinary Ctr Biobanking Lubeck, Lubeck, Germany
[2] Univ Lubeck, IT Ctr Clin Res, Lubeck, Germany
[3] Translat Res Coordinat Int Breast Canc Study Grp, Bern, Switzerland
[4] European Thorac Oncol Platform, Bern, Switzerland
[5] European Middle Eastern & African Soc Biopreserva, Brussels, Belgium
[6] Univ Lubeck, Dept Surg, Sect Translat Surg Oncol & Biobanking, Campus Lubeck Ratzeburger Allee 160, D-23538 Lubeck, Germany
[7] Univ Hosp Schleswig Holstein UKSH, Campus Lubeck Ratzeburger Allee 160, D-23538 Lubeck, Germany
关键词
Biobank; pre-analytics; precision medicine; BROAD CONSENT; QUALITY ASSESSMENT; RARE DISEASES; DRUG; BIOSPECIMENS; CANCER; GENOMICS; IMPACT; IMPLEMENTATION; HETEROGENEITY;
D O I
10.1080/23808993.2019.1690395
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Precision medicine aims for improving the efficiency of individual therapies. This requires that the attending physicians have access to reliable data also within the research context. Clinical biobanks are capable of obtaining and processing high-quality samples and data under standardized conditions, ensuring ethics and data protection, and providing the physician with research results. Areas covered: This article describes the functions and responsibilities of biobanks within clinical everyday life and shows how biobanks as bridging infrastructures facilitate individualized therapies. The literature search was carried out using PubMed with the keywords listed below. Expert opinion: The increasing work density and task complexity of the clinical staff are among the greatest challenges to advance precision medicine. Health-care decisions will increasingly be made in expert translational units like the molecular tumor board. Clinical biobanks, as an interdisciplinary interface between treating physicians, bioinformaticians, pathologists and medical scientists, bundle critical tasks in the precision medicine workflow and facilitate stratified information exchange. However, this can only be achieved by the increased visibility of biobanks in hospitals and public, as well as through financial sustainability. Particularly biobanks with a certified/accredited structure, guaranteeing standardized workflows, will be able to close the gap between translational research and clinical practice.
引用
收藏
页码:309 / 316
页数:8
相关论文
共 50 条
  • [1] Standardizing digital biobanks: integrating imaging, genomic, and clinical data for precision medicine
    Valentina Brancato
    Giuseppina Esposito
    Luigi Coppola
    Carlo Cavaliere
    Peppino Mirabelli
    Camilla Scapicchio
    Rita Borgheresi
    Emanuele Neri
    Marco Salvatore
    Marco Aiello
    [J]. Journal of Translational Medicine, 22
  • [2] Standardizing digital biobanks: integrating imaging, genomic, and clinical data for precision medicine
    Brancato, Valentina
    Esposito, Giuseppina
    Coppola, Luigi
    Cavaliere, Carlo
    Mirabelli, Peppino
    Scapicchio, Camilla
    Borgheresi, Rita
    Neri, Emanuele
    Salvatore, Marco
    Aiello, Marco
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [3] Toward a Standardized Strategy of Clinical Metabolomics for the Advancement of Precision Medicine
    Nguyen Phuoc Long
    Tran Diem Nghi
    Kang, Yun Pyo
    Nguyen Hoang Anh
    Kim, Hyung Min
    Park, Sang Ki
    Kwon, Sung Won
    [J]. METABOLITES, 2020, 10 (02)
  • [4] How Sensors, Devices, and Biomarkers Can Transform Precision Medicine: Perspectives From a Clinical and Translational Science Institute
    Maron, Jill L.
    Jones, Graham B.
    [J]. CLINICAL THERAPEUTICS, 2018, 40 (02) : 345 - 348
  • [5] Redesign of Clinical Decision Systems to Support Precision Medicine
    Afzal, Muhammad
    Hussain, Maqbool
    Lee, Sungyoung
    Khattak, Hasan Ali
    [J]. PROCEEDINGS OF TENCON 2018 - 2018 IEEE REGION 10 CONFERENCE, 2018, : 2259 - 2263
  • [6] How Real-World Data Can Facilitate the Development of Precision Medicine Treatment in Psychiatry
    Koch, Elise
    Pardinas, Antonio F.
    O'Connell, Kevin S.
    Selvaggi, Pierluigi
    Collados, Jose Camacho
    Babic, Aleksandar
    Marshall, Serena E.
    van der Eycken, Erik
    Angulo, Cecilia
    Lu, Yi
    Sullivan, Patrick F.
    Dale, Anders M.
    Molden, Espen
    Posthuma, Danielle
    White, Nathan
    Schubert, Alexander
    Djurovic, Srdjan
    Heimer, Hakon
    Stefansson, Hreinn
    Stefansson, Kari
    Werge, Thomas
    Sonderby, Ida
    O'Donovan, Michael C.
    Walters, James T. R.
    Milani, Lili
    Andreassen, Ole A.
    [J]. BIOLOGICAL PSYCHIATRY, 2024, 96 (07) : 543 - 551
  • [7] HOW CAN LAW SUPPORT DEVELOPMENT OF GENOMICS AND PRECISION MEDICINE TO ADVANCE HEALTH EQUITY AND REDUCE DISPARITIES? Foreword
    Wolf, Susan M.
    Bonham, Vence L.
    Bruce, Marino A.
    [J]. ETHNICITY & DISEASE, 2019, 29 : 623 - 628
  • [8] Editorial: How Can Genomic Biobanks Provide the Bridge for Implementation of Effective Clinical Therapy?
    Przygodzki, Ronald M.
    [J]. FRONTIERS IN PUBLIC HEALTH, 2020, 8
  • [9] HLA-based precision medicine can be a clinical reality
    Hosomichi, Kazuyoshi
    [J]. GENES & GENETIC SYSTEMS, 2016, 91 (06) : 318 - 318
  • [10] Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine
    Albert-Vega, Chloe
    Tawfik, Dina M.
    Trouillet-Assant, Sophie
    Vachot, Laurence
    Mallet, Francois
    Textoris, Julien
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9